AmCham News

AmCham Healthcare Committee Brings Industry Priorities to Prime Minister’s Council

19 Nov 2026, 11:54 AmCham Healthcare Committee Brings Industry Priorities to Prime Minister’s Council

On November 16, AmCham Kazakhstan’s healthcare priorities were discussed at a meeting of the Prime Minister’s Council to Improve the Investment Climate, chaired by Prime Minister Olzhas Bektenov and focused on investment and innovation in Kazakhstan’s healthcare sector.

The agenda reflected issues developed through AmCham’s Healthcare Committee and followed the Committee’s Healthcare Innovation Roundtable held on November 13, where AmCham member companies discussed key barriers to investment, innovation, and patient access and developed practical recommendations for government dialogue.

AmCham’s healthcare agenda focused on four interconnected areas:

  • Access to medicines and healthcare financing — improving mechanisms for funding and reimbursement and expanding patient access to modern treatments;
  • Sustainable access to orphan medicines — improving approaches to orphan-drug status, procurement and continuity of therapy for patients with rare diseases;
  • Pricing and regulatory predictability — including the publication of pricing orders and creating greater predictability around the regulatory framework;
  • Contract manufacturing and localization — supporting investment in local production while ensuring stable investment conditions, protection of intellectual property, and predictable rules.

At the Council meeting, these priorities were presented by AmCham Executive Director Jeff Erlich, U.S. Ambassador Julie Stufft, and representatives of AmCham member companies Johnson & Johnson, AstraZeneca, and Pfizer. The government side included Prime Minister Bektenov, Deputy Prime Minister and Minister of National Economy Serik Zhumangarin, and Minister of Healthcare Akmaral Alnazarova.

AmCham appreciates the Government’s continued openness to dialogue with the international business community and the opportunity to bring practical industry perspectives directly into discussions on Kazakhstan’s investment climate.

The Prime Minister instructed relevant government bodies to review the proposals from international pharmaceutical companies and work on measures to further improve the investment climate, including investment attraction, localization, advanced technologies, and access to quality healthcare.

We thank the Prime Minister, the Ministry of Healthcare, and other government stakeholders for their engagement and look forward to continuing the dialogue and working together on practical solutions that can support both Kazakhstan’s healthcare outcomes and its attractiveness as a destination for investment.